Fig. 1From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE studyALPINE Study Design and Exploratory Outcome Schedule. aCaregiver-reported outcome; the baseline assessment for the Burden Assessment Scale was completed during the screening period. bPatient-reported outcome. CGI-S, Clinical Global Impression-Severity; IM, intramuscular; PANSS, Positive and Negative Syndrome Scale; Q-LES-Q-SF, Quality of Life Enjoyment and Satisfaction Questionnaire–Short FormBack to article page